These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31421265)

  • 1. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.
    Elnaggar MH; Abushouk AI; Hassan AHE; Lamloum HM; Benmelouka A; Moatamed SA; Abd-Elmegeed H; Attia S; Samir A; Amr N; Johar D; Zaky S
    Semin Cancer Biol; 2021 Feb; 69():91-99. PubMed ID: 31421265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
    Zhang X; Ng HLH; Lu A; Lin C; Zhou L; Lin G; Zhang Y; Yang Z; Zhang H
    Nanomedicine; 2016 May; 12(4):853-869. PubMed ID: 26772424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
    Kumar V; Rahman M; Gahtori P; Al-Abbasi F; Anwar F; Kim HS
    Expert Opin Drug Deliv; 2021 Jun; 18(6):673-694. PubMed ID: 33295218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in hepatocellular carcinoma-targeted nanoparticles.
    Liu X; Bai Y; Zhou B; Yao W; Song S; Liu J; Zheng C
    Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
    Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
    Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.
    Lu J; Wang J; Ling D
    Small; 2018 Feb; 14(5):. PubMed ID: 29251419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
    Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
    Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma.
    Kong FH; Ye QF; Miao XY; Liu X; Huang SQ; Xiong L; Wen Y; Zhang ZJ
    Theranostics; 2021; 11(11):5464-5490. PubMed ID: 33859758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid adipocyte-derived exosome nano platform for potent chemo-phototherapy in targeted hepatocellular carcinoma.
    Liu X; Zhang J; Zheng S; Li M; Xu W; Shi J; Kamei KI; Tian C
    J Control Release; 2024 Jun; 370():168-181. PubMed ID: 38643936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma.
    Rahman M; Almalki WH; Alrobaian M; Iqbal J; Alghamdi S; Alharbi KS; Alruwaili NK; Hafeez A; Shaharyar A; Singh T; Waris M; Kumar V; Beg S
    Expert Opin Drug Deliv; 2021 Apr; 18(4):489-513. PubMed ID: 33225771
    [No Abstract]   [Full Text] [Related]  

  • 15. Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update.
    Fan QQ; Tian H; Cheng JX; Zou JB; Luan F; Qiao JX; Zhang D; Tian Y; Zhai BT; Guo DY
    Biomed Pharmacother; 2024 Aug; 177():117118. PubMed ID: 39002440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicines: a theranostic approach for hepatocellular carcinoma.
    Usmani A; Mishra A; Ahmad M
    Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):680-690. PubMed ID: 28884605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy
    Xiang Y; Huang W; Huang C; Long J; Zhou Y; Liu Y; Tang S; He DX; Tan XW; Wei H; Yu CY
    Mol Pharm; 2020 Sep; 17(9):3223-3235. PubMed ID: 32658485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy.
    Ungureanu BS; Teodorescu CM; Săftoiu A
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):375-83. PubMed ID: 27689203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 20. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.